ARGEO AS financials
ARGEO AS
894500SHXBC6FQ4L8U37 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | $52.0M | $7.2M |
| Cost of sales | $41.3M | $14.5M |
| Gross profit | $12.2M | -$4.4M |
| Other income | $1.5M | $2.9M |
| Operating expenses | $14.9M | $9.2M |
| Depreciation & amortisation | $9.4M | $4.7M |
| Operating profit (EBIT) | -$2.7M | -$13.7M |
| Net finance income / (cost) | -$4.2M | -$3.2M |
| Finance costs | $6.3M | $1.8M |
| Profit before tax | -$6.8M | -$16.9M |
| Income tax expense | $123.0K | $79.0K |
| Profit for the year | -$6.9M | -$16.9M |
| — attributable to owners | -$6.9M | -$16.9M |
| Total comprehensive income | -$9.6M | -$15.9M |
| Per share | ||
| Basic EPS | $-0.16 | $-0.82 |
| Diluted EPS | $-0.16 | $-0.82 |
| Free cash flow / share | $-0.35 | $-1.22 |
| Cash flow statement | ||
| Net cash from operating activities | $3.6M | -$4.2M |
| Net cash from investing activities | -$20.4M | -$22.8M |
| Purchase of PP&E (capex) | $18.6M | $21.1M |
| Net cash from financing activities | $11.8M | $30.3M |
| Lease liability payments | $5.8M | $2.2M |
| Net change in cash | -$5.0M | $3.2M |
| Balance sheet | ||
| Total assets | $99.3M | $71.6M |
| Non-current assets | $78.0M | $59.3M |
| Property, plant & equipment | $43.0M | $36.3M |
| Right-of-use assets | $26.1M | $18.5M |
| Current assets | $21.3M | $12.3M |
| Trade & other receivables | $6.9M | $219.0K |
| Cash & equivalents | $827.0K | $5.3M |
| Total equity | $32.9M | $35.0M |
| Non-current liabilities | $35.4M | $18.1M |
| Long-term borrowings | $18.6M | $4.9M |
| Lease liabilities (non-current) | $16.8M | $13.1M |
| Current liabilities | $31.0M | $18.5M |
| Lease liabilities (current) | $7.6M | $4.8M |
| Trade & other payables | $11.2M | $6.5M |
| Derived metrics | ||
| Free cash flow | -$15.0M | -$25.3M |
| Operating margin | -5.1% | -189.5% |
| Net margin | -13.3% | -234.9% |
| Return on equity | -21.1% | -48.4% |
| Cash conversion ratio | -0.51× | 0.25× |
| Capex coverage | 0.19× | -0.20× |
| Other reported items | ||
| Adjustments For Decrease Increase In Trade and Other Receivables | -$14.1M | $2.0M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $9.2M | $7.4M |
| Adjustments For Finance Income Cost | -$4.4M | -$3.2M |
| Adjustments For Increase Decrease In Trade Account Payable | $4.7M | $4.0M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | $82.0K | $0 |
| Adjustments For Provisions | $438.0K | -$385.0K |
| Adjustments For Sharebased Payments | $768.0K | $13.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | $122.0K | $0 |
| Comprehensive Income Attributable To Owners of Parent | -$9.6M | -$15.9M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | $2.4M | $2.4M |
| Current Contract Assets | $297.0K | $552.0K |
| Current Contract Liabilities | $6.9M | $2.2M |
| Current Provisions | $870.0K | $432.0K |
| Current Tax Liabilities Current | $125.0K | $0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $512.0K | -$28.0K |
| Equity and Liabilities | $99.3M | $71.6M |
| Finance Income | $49.0K | $55.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | $2.2M | -$1.4M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $0 | $2.7M |
| Increase Decrease Through Sharebased Payment Transactions | $768.0K | $93.0K |
| Intangible Assets Other Than Goodwill | $4.9M | $3.8M |
| Interest Received Classified As Investing Activities | $51.0K | $53.0K |
| Investments In Joint Ventures Accounted For Using Equity Method | $0 | $152.0K |
| Issue of Equity | $6.8M | $36.2M |
| Issued Capital | $2.2M | $1.9M |
| Liabilities | $66.4M | $36.6M |
| Noncurrent Provisions | $1.0K | $2.0K |
| Other Comprehensive Income | -$2.7M | $1.1M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -$2.7M | $1.1M |
| Other Current Assets | $1.8M | $2.1M |
| Other Current Liabilities | $1.9M | $2.3M |
| Other Current Receivables | $11.5M | $4.1M |
| Payments For Development Project Expenditure | $1.4M | $1.5M |
| Proceeds From Issuing Shares | $6.8M | $36.2M |
| Proceeds From Noncurrent Borrowings | $22.7M | $2.6M |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $2.6M | $0 |
| Repayments of Noncurrent Borrowings | $5.9M | $5.3M |
| Revenue and Operating Income | $53.5M | $10.1M |
| Selling General and Administrative Expense | $5.5M | $1.9M |
| Share of Profit Loss of Joint Ventures Accounted For Using Equity Method | -$66.0K | -$81.0K |
| Share Premium | $68.7M | $62.2M |
Every line item above is a fact tagged in ARGEO AS's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.